Part III | Chapter 11 228 83. Bettermann AS, Zamboglou C, Kiefer S, Jilg CA, Spohn S, Kranz-Rudolph J, et al. [68Ga-]PSMA-11 PET/CT and multiparametric MRI for gross tumor volume delineation in a slice by slice analysis with whole mount histopathology as a reference standard – Implications for focal radiotherapy planning in primary prostate cancer. Radiother Oncol 2019;141:214–9. 84. Liu W, Fakir H, Randhawa G, Alfano R, Corkum M, Kassam Z, et al. Defining radio-recurrent intraprostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRI. Clin Transl Radiat Oncol 2022;32:41–7. 85. Morton G, McGuffin M, Chung HT, Tseng C-L, Helou J, Ravi A, et al. Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy. Radiother Oncol 2020;146:90–6. 86. Leroy T, Lacornerie T, Bogart E, Nickers P, Lartigau E, Pasquier D. Salvage robotic SBRT for local prostate cancer recurrence after radiotherapy: preliminary results of the Oscar Lambret Center. Radiat Oncol 2017;12:95. 87. Loi M, Di Cataldo V, Simontacchi G, Detti B, Bonomo P, Masi L, et al. Robotic Stereotactic Retreatment for Biochemical Control in Previously Irradiated Patients Affected by Recurrent Prostate Cancer. Clin Oncol (R Coll Radiol) 2018;30:93–100. 88. Jereczek-Fossa BA, Rojas DP, Zerini D, Fodor C, Viola A, Fanetti G, et al. Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT). Br J Radiol 2019;92:20180494. 89. D’Agostino GR, Di Brina L, Mancosu P, Franzese C, Iftode C, Franceschini D, et al. Reirradiation of Locally Recurrent Prostate Cancer With Volumetric Modulated Arc Therapy. Int J Radiat Oncol Biol Phys 2019;104:614–21. 90. Mbeutcha A, Chauveinc L, Bondiau PY, Chand ME, Durand M, Chevallier D, et al. Stereotactic prostate focal reirradiation therapy for local recurrence: preliminary results of Hartmann Oncology Radiotherapy Group. Br J Radiol 2019;105:275–81. 91. Scher N, Bauduceau O, Bollet M, Lamallem H, Charas T, Garaud P, et al. Stereotactic prostate focal reirradiation therapy for local recurrence: preliminary results of Hartmann Oncology Radiotherapy Group. BJR Open 2019;1:20180027. 92. Fuller D, Wurzer J, Shirazi R, Bridge S, Law J, Crabtree T, et al. Retreatment for Local Recurrence of Prostatic Carcinoma After Prior Therapeutic Irradiation: Efficacy and Toxicity of HDR-Like SBRT. Int J Radiat Oncol Biol Phys 2020;106:291–9. 93. Caroli P, Colangione SP, De Giorgi U, Ghigi G, Celli M, et al. (68)Ga-PSMA-11 PET/CT-Guided Stereotactic Body Radiation Therapy Retreatment in Prostate Cancer Patients with PSA Failure after Salvage Radiotherapy. Biomedicines 2020;8. 94. Bergamin S, Eade T, Kneebone A, Booth J, Hsiao E, Schembri GP, et al. Interim Results of a Prospective Prostate-Specific Membrane Antigen-Directed Focal Stereotactic Reirradiation Trial for Locally Recurrent Prostate Cancer. Int J Radiat Oncol Biol Phys 2020;108:1172–8. 95. Cuccia F, Nicosia L, Mazzola R, Figlia V, Giaj-Levra N, Ricchetti F, et al. Linac-based SBRT as a feasible salvage option for local recurrences in previously irradiated prostate cancer. Strahlenther Onkol 2020;196:628–36. 96. Matrone F, Revelant A, Fanetti G, Polesel J, Chiovati P, Avanzo M, et al. Partial prostate re-irradiation for the treatment of isolated local recurrence of prostate cancer in patients previously treated with primary external beam radiotherapy: short-term results of a monocentric study. Neoplasma 2021;68:216–26. 97. Michalet M, Riou O, Valdenaire S, Debuire P, Ailleres N, Draghici R, et al. Magnetic Resonance-Guided Reirradiation for Local Recurrence Within the Prostate or in the Prostate Bed: Preliminary Results of a Prospective Registry Study. Adv Radiat Oncol 2021;6:100748. 98. Zhong J, Slevin F, Scarsbrook AF, Serra M, Choudhury A, Hoskin PJ, et al. Salvage Reirradiation Options for Locally Recurrent Prostate Cancer: A Systematic Review. Front Oncol 2021;11. 99. Cuccia F, Corradini S, Mazzola R, Spiazzi L, Rigo M, Bonù ML, et al. MR-Guided Hypofractionated Radiotherapy: Current Emerging Data and Promising Perspectives for Localised Prostate Cancer. Cancers 2021;13. 100. Chaiswing L, Weiss HL, Jayswal RD, Clair DKS, Kyprianou N. Profiles of Radioresistance Mechanisms in Prostate Cancer. Crit Rev Oncog 2018;23:39–67. 101. Supiot S, Rousseau C, Dore M, Chèze-Le-Rest C, Kandel-Aznar C, Potiron V, et al. Reoxygenation during radiotherapy in intermediate-risk prostate cancer. Radiother Oncol 2019;133:16–9.
RkJQdWJsaXNoZXIy MTk4NDMw